Article
Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
Atherosclerosis - 1 Nov 1991
Maher V M, Gallagher J J, Thompson G R, Myant N B
Abstract excerpt
The effect of cholestyramine and simvastatin, given separately or in combination, on serum lipid concentrations in 11 patients with heterozygous familial defective apolipoprotein B-100 was compared with that in 11 matched patients with heterozygous familial hypercholesterolaemia. In both groups o...
Topics
- Adult
- Aged
- Anticholesteremic Agents
- Apolipoprotein B-100
- Apolipoproteins B
- Apolipoproteins E
- Cholesterol
- Cholesterol, LDL
- Cholestyramine Resin
- Drug Therapy, Combination
- Female
- Heterozygote
- Humans
- Hypercholesterolemia
- Lovastatin
- Male
- Middle Aged
- Phenotype